Manufacturing QA Upgrades May Reduce Drug Recalls, FDA’s Woodcock Says

Industry adoption of quality assurance manufacturing technologies based on predictive, analytical models could help reduce drug recalls and shortages, Center for Drug Evaluation & Research Director Janet Woodcock, MD, suggested Nov. 16